Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 27516
Event :DPharm: Disruptive Clinical Trials US - September 25-26,2018 - Boston, MA

Dates :Tuesday September 25th, 2018 - Wednesday September 26th, 2018

Location :Boston Marriott Copley Place
110 Huntington Ave
02116 Boston, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

DPharm is where the clinical trials industry gathers to report on the latest disruptive and innovative projects to advance clinical trials.
 
DPharm 2018 is the year of patient data ownership, all things digital, and new approaches to optimize clinical systems. Co-chairs Dr Sylke Poehling, SVP and Global Head, Strategy, Portfolio and Clinical Operations, Roche, Dr Andreas Koester, VP and Global Head, Janssen Clinical Innovation, Janssen, and Craig Lipset, Head of Clinical Innovation, RandD, Pfizer, Inc, host 70+ speakers, who are challenging conventional thinking and inspiring new ideas to reduce the burden on patients, investigators and sites. DPharm is divided into the following sections: keynotes, strategic level talks, pharma innovation reporting, new and advanced technologies, patient data access and ownership, digital biomarkers, digital/virtual trials, AI/machine learning, clinical research as a care option (CRAACO), and service as a disruptor in RandD. DPharm also has a pre-conference day dedicated to all things mobile and sensors in clinical trials, which is chaired by Dr Dan Karlin, Head of Clinical, Informatics, and Regulatory Strategy, Digital Medicine, Pfizer. 
 
DPharm:
- is a TED-style event showcasing innovations from leading Pharma RandD practitioners and from other industries.
- underscores the promise and challenge of innovation in advancing drug development.
- features new models and collaborations to get therapeutics to patients faster.
- features the full spectrum of clinical research options and utilizes insights more appropriately.
- is dedicated to challenging creative solutions and finding a way to implement them.
- explores to whom companies are being disruptive and to gain a better understanding of the impact on clinical trials.
 
From experienced radical thinkers to those new in the trenches are all welcome! 
 
Prices:
Pharma and Biotech rate: USD 2095.0
Standard Industry rate: USD 2095.0
Academic / Non-profit / Govt. rate: USD 1047.5
 
Speakers: Andreas Koester MD PhD, Craig Lipset MBA, Sylke Poehling PhD, Murray Abramson MD, Chip Bell, Carolyn Brehm, Jennifer Byrne, Aneesh Chopra, Andy Coravos, Esther Dyson, Richie Etwaru, Felipe Feijoo PhD, Cindy Geoghegan, Rob Goodwin, Christian Gossens PhD MBA, Gary Grabow, Shwen Gwee, Judy Hung MD, Jonathan Jackson PhD, Mark Johnston, Hassan Kadhim, Joseph Kim MBA, Harlan Krumholz MD, Michael Ku, Jacob LaPorte PhD, Sarah Luijpers, Arjun Manrai PhD, Kelly McKee, Amy Nordo, Indrek Onnik, Ulo Palm, Chandra Ramanathan PhD MBA, Dan Rothman, Jessica Scott MD JD, Mark Scrimshire, Michelle Shogren, Kim Smyth MBA, Jaydev Thakkar MBA, Bill Thornton MBA, John Varaklis, Amy Zwaniger
 
Time: 8:00 am - 6:00 pm
 

Location

Map and directions
Conference address :
Boston Marriott Copley Place
110 Huntington Ave
02116 Boston
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

DPharm: Disruptive Clinical Trials US - September 25-26,2018 - Boston, MA Pharmacy
clinical, drug development, health, medicine
Everyone
-- -- --
English

Other

For more information on DPharm: Disruptive Clinical Trials US - September 25-26,2018 - Boston, MA, plsase contactr evvnt Platform

To display announcer website, obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event